In particular, a male Balb/C mice model of acute pancreatitis induced lung injury has been treated with several epigallocatechin-3-gallate dosages (5, 10, 20, 40, and 80 mg/kg) (0.4, 0.8, 1.6, and 3.2 mg/kg HED) for 4 weeks, and a notably dose-dependent decrease in IL-1β inflammation factor has been observed after treatment. This evidence concerns the gene IL1B and acute pancreatitis.